Blood test may predict sepsis danger
NCT ID NCT06446947
First seen Feb 14, 2026 · Last updated Jun 22, 2026 · Updated 16 times
Summary
This study aims to find epigenetic markers in the blood that could predict whether a patient with sepsis will develop the more dangerous septic shock. Researchers will take blood samples from 25 male patients after major digestive cancer surgery who develop sepsis. By comparing markers between those who worsen and those who don't, they hope to identify early warning signs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service Anesthésie Réanimation - Hôpital Nord - Assistance Publique Hôpitaux de Marseille
RECRUITINGMarseille, Bouches du Rhône, 13015, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors identify which sepsis patients are at risk of worsening to septic shock, allowing earlier and more targeted treatment.
What could go wrong
This is a very small, early-stage study with only 25 male patients after specific surgeries, so results may not apply to all sepsis patients and may not lead to a practical test.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.